1.

Which of the following has issued an emergency use authorisation (EUA) for a combination of drugs--casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 symptoms?

A. US Food and Drug Administration
B. Centers for Disease Control and Prevention
C. Occupational Safety and Health Administration
D. Drug Enforcement Administration
E. Therapeutic Goods Administration
Answer» B. Centers for Disease Control and Prevention


Discussion

No Comment Found